Metamizole-induced agranulocytosis (MIA): a mini review
Abstract Metamizole is an analgesic, antipyretic, and spasmolytic drug in Germany only approved for the treatment of severe pain or high fever that does not respond to other measures. In recent years, an increased use has been described among both adults and children, often against the approved indi...
Saved in:
Main Authors: | Markos K. Tomidis Chatzimanouil (Author), Ines Goppelt (Author), Yvonne Zeissig (Author), Ulrich J. Sachs (Author), Martin W. Laass (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Agranulocytosis due to metamizole, is it time to restrict its prescription?
by: Raquel Cobos Campos, et al.
Published: (2024) -
Drug-Induced Neutropenia and Agranulocytosis
by: O. D. Ostroumova, et al.
Published: (2020) -
Drug-induced agranulocytosis: Case series
by: Čolović Nataša R., et al.
Published: (2018) -
Ritodrine-Induced Agranulocytosis: A Case Report and Literature Review
by: Atsushi Daimon, et al.
Published: (2020) -
Dapsone-induced agranulocytosis in patients with Hansen's disease
by: Tania Rita Moreno de Oliveira Fernandes, et al.
Published: (2017)